Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Lower Back Pain & Sciatica - Forecast in 9 Major Markets 2016-2026 - Research and Markets

Research and Markets
Posted on: 19 Oct 16

Research and Markets has announced the addition of the "Lower Back Pain and Sciatica Forecast in 9 Major Markets 2016-2026" report to their offering.

Low back pain (LBP) is defined as experiencing musculoskeletal pain, muscle tension, or stiffness localized below the bottom edge of the rib cage and above the gluteal sulcus, with or without sciatica, and is defined as chronic when it persists for 12 weeks or more. This pain may be caused by a variety of diseases and disorders that affect the lumbar spine region.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Lower Back Pain have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Key co-morbidities for LBP include:

  • Smoking
  • Obesity & overweight
  • Arthritis
  • Neuropathic components

Reasons to Buy:

  • Able to quantify patient populations in global Lower Back Pain market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Lower Back Pain and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Lower Back Pain's prevalent population.
  • Identify sub-populations within Lower Back Pain which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Lower Back Pain patients

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Sciatica

6. Variation by Geography/Ethnicity

7. Disease Prognosis & Clinical Course

8. Key comorbid conditions/Features associated with the disease

9. Methodology for quantification of patient numbers

10. Top-line prevalence for Lower Back Pain

11. Features of Lower Back Pain Patients

12. Co-morbid conditions in Lower Back Pain

13. Top Line prevalence for Sciatica

14. Features of Sciatica Patients

15. Abbreviations used in the report

16. Patient-Based Offering

17. Online Pricing Data and Platforms

18. References

19. Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 19/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.